AMSBIO has introduced GMP-grade StemFit® for Differentiation, a cutting-edge, chemically defined, and animal-origin free medium optimized for the differentiation of human induced pluripotent stem (hiPS) and embryonic stem (hES) cells. With full compliance to Good Manufacturing Practices (GMP), this medium is ideal for both research and clinical applications.

By eliminating animal-derived components and minimizing batch variability, StemFit® for Differentiation ensures reproducible and contamination-free differentiation outcomes. Its GMP-grade status makes it especially relevant for translational and clinical laboratories.

Key Features of GMP-Grade StemFit® for Differentiation

• Chemically defined formulation ensures reproducibility across batches.

• Animal component-free to reduce immunogenic risks.

• Fully GMP-compliant for downstream clinical application.

• Compatible with other GMP StemFit® products including Basic03, Basic04 CT.

• Cost-effective transition to GMP with minimal financial impact.

As all StemFit® formulations transition to GMP-grade by the end of 2025, laboratories will benefit from streamlined regulatory pathways and simplified workflows from discovery to therapy.